[Federal Register Volume 60, Number 119 (Wednesday, June 21, 1995)]
[Notices]
[Page 32323]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-15188]



-----------------------------------------------------------------------

FEDERAL TRADE COMMISSION
[Dkt. C-3573]


Boston Scientific Corporation; Prohibited Trade Practices, and 
Affirmative Corrective Actions

AGENCY: Federal Trade Commission.

ACTION: Consent order.

-----------------------------------------------------------------------

SUMMARY: In settlement of alleged violations of Federal law prohibiting 
unfair acts and practices and unfair methods of competition, this 
consent order permits, among other things, Boston Scientific 
Corporation, a Massachusetts-based manufacturer and marketer of 
catheters, to proceed with the proposed acquisitions of Cardiovascular 
Imaging Systems, Inc., and SCIMED Life Systems, Inc., but requires the 
respondent to grant a nonexclusive license to a specified package of 
patents and technology related to the manufacture, production and sale 
of intravascular ultrasound (IVUS) imaging catheters to the Hewlett-
Packard Company or another Commission-approved licensee. In addition, 
the consent order requires the respondent to obtain Commission 
approval, for ten years, before acquiring an interest greater than one 
percent in a company engaged in researching, developing or 
manufacturing IVUS catheters for sale in the United States.

DATES: Complaint and Order issued April 28, 1995.\1\

    \1\Copies of the Complaint, the Decision and Order, and 
Commissioner Azcuenaga's statement are available from the 
Commission's Public Reference Branch, H-130, 6th Street & 
Pennsylvania Avenue, NW., Washington, D.C. 20580.

FOR FURTHER INFORMATION CONTACT:
Howard Morse or Robert Tovsky, FTC/S-3627, Washington, D.C. 20580. 
(202) 326-2949 or 326-2634.

SUPPLEMENTARY INFORMATION: On Thursday, March 9, 1995, there was 
published in the Federal Register, 60 FR 12948, a proposed consent 
agreement with analysis In the Matter of Boston Scientific Corporation, 
for the purpose of soliciting public comment. Interested parties were 
given sixty (60) days in which to submit comments, suggestions or 
objections regarding the proposed form of the order.
    No comments having been received, the Commission has ordered the 
issuance of the complaint in the form contemplated by the agreement, 
made its jurisdictional findings and entered an order to cease and 
desist, as set forth in the proposed consent agreement, in disposition 
of this proceeding.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interpret or apply sec. 5, 38 
Stat. 719, as amended; sec. 7, 38 Stat. 731, as amended; 15 U.S.C. 
45, 18)
Benjamin I. Berman,
Acting Secretary.
[FR Doc. 95-15188 Filed 6-20-95; 8:45 am]
BILLING CODE 6750-01-M